Thursday, July 2, 2026
ADVT 
International

US B-1 bombers strike deep inside Iran

Darpan News Desk IANS, 02 Mar, 2026 01:54 PM
  • US B-1 bombers strike deep inside Iran

The US' B-1 bombers struck deep inside Iran overnight, targeting what American officials described as the country's ballistic missile capabilities, as tensions escalated sharply in the region.

US Central Command (CENTCOM) said on Monday that the strikes were aimed at degrading Tehran's missile arsenal.

"Last night, US' B-1 bombers, struck deep inside Iran to degrade Iranian ballistic missile capabilities," CENTCOM said in a statement on social media platform X.

The operation comes amid an expanding US military campaign branded Operation 'Epic Fury'.

The White House signalled the strikes were part of a broader effort to cripple Iran's weapons infrastructure.

As the US President Donald Trump said, "we're going to destroy their missiles and raze their missile industry to the ground," CENTCOM quoted Trump as saying.

The CENTCOM also pushed back against what it described as Iranian misinformation about battlefield losses.

"The Iranian regime's false messaging machine continues to falsely claim that it has sunk a US aircraft carrier," CENTCOM said.

It added: "The TRUTH: The only carrier that has been hit is the Shahid Bagheri, an Iranian drone carrier. The US forces struck the ship within hours of launching Operation Epic Fury."

CENTCOM did not provide immediate details on the specific sites targeted by the B-1 bombers or the extent of damage inflicted.

The B-1 is a long-range strategic bomber capable of carrying large payloads of conventional weapons and operating deep inside hostile territory.

The strikes follow continued missile launches by Iran across the region.

"Iran continues to maliciously launch ballistic missiles, indiscriminately targeting military and civilian locations throughout the region," CENTCOM said.

The Command added that US forces are actively pursuing Iranian missile units.

"US forces remain on the hunt to eliminate this threat. As the President has said, our resolve has never been stronger."

The latest developments mark a significant escalation in direct US military action inside Iranian territory.

While previous exchanges largely involved proxy forces or strikes in third countries, the use of B-1 bombers deep inside Iran signals a more overt phase of confrontation.

The Persian Gulf and surrounding waterways are critical to global energy supplies, including shipments bound for Asian markets such as India.

Any sustained conflict risks disruption to oil flows and regional security architecture.

Picture Courtesy: IANS

MORE International ARTICLES

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided